- Atlas
- Medicine & Health
- Radiation Oncology
Radiation Oncology
Radiation oncology is the branch of cancer medicine that uses ionizing radiation—high-energy rays or particles that can strip electrons from atoms and damage DNA—to destroy tumors.
11 frameworks, from 1896 to today · Oncology · Medicine & Health
- Empirical radiotherapy 1896-1925
- Brachytherapy 1910-Present
- Dose fractionation 1920-Present
- Dosimetry and Radiological Physics 1925-Present
- Megavoltage External-Beam Therapy 1950-Present
- Particle Therapy 1955-Present
- Radiosurgery 1968-Present
- Randomized Trial Evidence Base 1970-Present
- Three-Dimensional Conformal Radiotherapy 1985-Present
- Intensity-Modulated Radiation Therapy 1995-Present
- Image-Guided and Adaptive Radiotherapy 2000-Present
Overview
Radiation oncology is the branch of cancer medicine that uses ionizing radiation—high-energy rays or particles that can strip electrons from atoms and damage DNA—to destroy tumors1. Its practitioners, radiation oncologists, work with physicists and technologists to aim a controlled dose at a cancer while sparing the healthy tissue around it1. The field's history is a long negotiation between two facts: radiation kills dividing cells, and it also damages normal tissue. Almost every advance described below is a new answer to the question of how to widen the gap between the tumor dose and the dose to everything else.
Discovery and the First Treatments, 1895–1920
Wilhelm Röntgen discovered X-rays in November 1895, and within months physicians were experimenting with them. Henri Becquerel found in 1896 that uranium salts emitted penetrating rays, and Marie and Pierre Curie isolated radium in 1898. The first therapeutic uses followed almost immediately: reports of X-ray treatment of breast cancer and skin lesions appeared in 1896, and radium was applied to skin cancers and other surface tumors soon after. These early treatments were empirical. Nobody knew what a dose was, and the biological rationale was simply that radiation seemed to shrink growths.
Two problems dominated the first two decades. The first was measurement. Early practitioners judged exposure by skin redness or by the glow of a fluorescent screen, which made treatment impossible to reproduce. The second was harm. Radiation caused burns, ulcers, and later cancers in patients and in the physicians who worked with it; many early radiologists lost fingers or died of radiation-induced disease. The recognition that dose had to be quantified and limited became the founding concern of the field.
The Birth of Dosimetry and Fractionation, 1920s–1930s
The unit that made radiotherapy a science was the roentgen, defined in 1928 as a measure of X-ray exposure in air. The International Commission on Radiological Units was established in the same period, and the International Commission on Radiological Protection followed in 1928, giving the field shared standards. Dosimetry—the measurement and calculation of the radiation dose delivered to tissue—became a discipline in its own right, carried out by physicists working alongside clinicians.
The second founding idea was fractionation: dividing a course of radiation into many smaller doses given over weeks rather than one large dose12. The French physician Claudius Regaud, working with radium at the Institut Curie in Paris, showed in the early 1900s that dividing the dose spared normal tissue while still sterilizing the tumor, and by the 1920s fractionation was becoming standard. The biological explanation came later: normal tissues repair radiation damage better than tumors do, and giving time between fractions lets them recover. The classic fractionation scheme that emerged—roughly 2 gray (Gy, the modern unit of absorbed dose) per day, five days a week, to a total of about 60 Gy—remained the backbone of curative radiotherapy for decades.
Brachytherapy: Sealed Sources and the Art of the Implant
Brachytherapy is the placement of a radioactive source directly into or next to a tumor, so that the tumor gets a high dose while the dose falls off steeply in surrounding tissue13. Radium needles and tubes were implanted in tumors of the cervix, tongue, and breast from the early 1900s. The Stockholm and Paris systems of the 1910s–1930s standardized how radium was arranged and how dose was specified for cervical cancer, and the Manchester system, developed in the 1930s, introduced a more systematic way of describing dose distributions around implants.
The field was transformed after the Second World War by artificial radionuclides made in reactors: iridium-192, cobalt-60, cesium-137, and iodine-125 replaced radium, and afterloading techniques—placing empty applicators first and loading the source afterward—reduced the radiation exposure of staff. In the 1960s the Paris system gave a unified method for specifying dose in interstitial implants. Remote-controlled afterloading machines, introduced in the 1960s, allowed high-dose-rate brachytherapy, in which a strong source is driven briefly into the applicator by machine rather than left in place for days. Modern brachytherapy is central to cervical, prostate, and breast treatment, and its dose planning is now done in three dimensions on imaging.
Megavoltage External-Beam Therapy, 1950s–1960s
External-beam therapy before the 1950s used X-rays of a few hundred kilovolts, which deposit most of their energy in the skin and shallow tissue1. This limited how deep a tumor could be treated and caused severe skin reactions14. The solution was higher-energy radiation. Cobalt-60 teletherapy units, which produce gamma rays of about 1.25 MeV, came into use in the 1950s, and medical linear accelerators (linacs) followed in the 1950s and 1960s, producing X-rays and electron beams in the megavoltage range. Megavoltage beams penetrate deeply, spare the skin (the maximum dose lies below the surface), and have a sharper edge, so tumors deep in the body could be treated curatively for the first time. The linac, refined continuously since, became the workhorse of the field1.
Imaging, Three-Dimensional Planning, and Conformal Therapy, 1970s–1990s
For most of the twentieth century, treatment planning was done on a single plane using X-ray films and hand calculations, and fields were shaped by lead blocks placed in the beam. Computed tomography, introduced in the early 1970s, changed this: for the first time the tumor and surrounding organs could be seen in cross-section, and dose could be calculated in three dimensions1. Treatment-planning computers made it practical to design beams that conformed to the tumor's shape from several directions1.
Three-dimensional conformal radiotherapy (3D-CRT), developed through the 1980s and 1990s, used CT-based planning and shaped fields—often with multileaf collimators, computer-controlled metal leaves that form the field edge—to fit the target volume while avoiding organs at risk. The concept of the planning target volume, a margin added around the visible tumor to account for uncertainty in positioning and motion, was formalized in the 1990s and became a standard vocabulary. 3D-CRT made dose escalation possible in prostate cancer and other sites and set the stage for the next step1.
Intensity-Modulated Radiation Therapy, 1990s–2000s
Intensity-modulated radiation therapy (IMRT) goes beyond shaping a field's outline: it varies the intensity of the beam across the field, using the multileaf collimator to create many small beamlets15. By combining beams from several angles, the planning system can produce a dose distribution that wraps around a concave or irregular target and pushes dose away from nearby sensitive structures—for example, sparing the spinal cord while treating a tumor wrapped around it, or sparing the parotid glands in head and neck cancer. IMRT grew out of inverse planning, in which the physician specifies the desired dose to tumor and organs and a computer algorithm searches for the beamlet intensities that best achieve it. It entered clinical use in the 1990s and spread widely in the 2000s. The trade-off is that a larger volume of normal tissue receives a low dose, and the technique demands rigorous quality assurance because small errors in delivery can produce large errors in dose.
Stereotactic Radiosurgery and Stereotactic Body Radiotherapy
Stereotactic radiosurgery delivers a single, very high dose to a small target with extreme geometric precision, using many converging beams16. The Swedish neurosurgeon Lars Leksell developed the concept and the Gamma Knife, first used clinically in 1968, for small brain lesions; it required a rigid head frame fixed to the skull to guarantee accuracy6. Linear-accelerator-based radiosurgery followed in the 1980s. The principle is that with enough precision, a dose that would be intolerable if spread over a large volume can be delivered safely to a tiny one.
Stereotactic body radiotherapy (SBRT) extended the idea to tumors outside the brain—in the lung, liver, spine, and prostate—using image guidance and motion management to track or account for breathing and setup variation. SBRT's high per-fraction doses (often around 10–20 Gy in a few fractions) exploit the greater sensitivity of some tumors to large doses and have produced high local control rates in early-stage lung cancer, offering an alternative to surgery for patients who cannot undergo an operation.
Randomized Trials and the Evidence Base, 1970s–Present
Radiotherapy's claims were increasingly tested in randomized controlled trials, the same instrument that reshaped medical oncology17. Landmark trials compared radiotherapy with surgery (for example, in early breast cancer, where breast-conserving surgery plus radiation proved equivalent in survival to mastectomy), tested adjuvant radiation after surgery, and settled questions of dose and fractionation. The demonstration that radiotherapy after breast-conserving surgery reduces recurrence became one of the foundations of modern breast cancer care1. Meta-analyses of many trials, coordinated by groups such as the Early Breast Cancer Trialists' Collaborative Group, quantified the benefits and the small but real risks of radiation, including second cancers and cardiac effects. The field's practice is now governed by evidence from such trials, and the randomized trial is as central to radiation oncology as to any branch of oncology1.
Image-Guided and Adaptive Radiotherapy, 2000s–Present
Even a perfect plan fails if the patient is in the wrong position or the tumor moves. Image-guided radiotherapy (IGRT) uses imaging at the time of treatment—X-ray, CT, ultrasound, or implanted markers—to verify and correct position before each fraction. Cone-beam CT mounted on the treatment machine, introduced in the 2000s, made daily three-dimensional verification routine. Adaptive radiotherapy goes further: it replans the treatment during the course to account for changes in tumor size or anatomy, such as a shrinking tumor or weight loss1. These techniques are essential for SBRT and for tumors near critical structures, and they have made highly conformal treatments reliable in practice.
Particle Therapy: Protons and Heavier Ions
Proton therapy uses beams of protons rather than X-rays8. Protons deposit most of their energy at a depth determined by their energy—the Bragg peak—and deliver almost nothing beyond it, so a tumor can be treated while tissue behind it receives little or no dose198. The idea dates to Robert Wilson's proposal in 1946, and clinical proton therapy began at research facilities in the 1950s and 1960s; hospital-based proton centers spread from the 1990s onward8. Heavier ions, notably carbon, have a similar physical advantage plus a higher biological effectiveness; carbon-ion therapy has been practiced mainly in Japan and Europe since the 1990s. Particle therapy's clinical advantage over advanced X-ray techniques is still being defined by trials, and its high cost and limited availability keep it a specialized option.
The Present
Radiation oncology today is a discipline of imaging, computation, and biology. Treatment planning is inverse and image-based; delivery is verified daily and increasingly adapted; hypofractionation—fewer, larger fractions—has become standard in several cancers, including breast and prostate, on the strength of trials. Molecular biology is beginning to inform how radiation is combined with drugs, including immunotherapy, and how individual tumors' radiosensitivity might be predicted1. The open questions are the ones the field has always faced in new form: how to deliver a tumoricidal dose with the least harm to normal tissue, how to identify which patients benefit from which technique, and how to integrate radiation with the systemic therapies that now dominate much of cancer care.
References
- Radiation therapy (introduction, Fractionation, Brachytherapy (sealed source radiotherapy), Conventional external beam radiation therapy, History, Dose, Virtual simulation, and 3-dimensional conformal radiation therapy, Intensity-modulated radiation therapy (IMRT), Stereotactic radiation, Types, Medical uses, Particle therapy, Estimation of dose based on target sensitivity), Wikipedia
- Dose fractionation, Wikipedia
- Brachytherapy, Wikipedia
- Moist desquamation, Wikipedia
- Multileaf collimator, Wikipedia
- Radiosurgery (introduction, History, Gamma Knife), Wikipedia
- Randomized controlled trial, Wikipedia
- Proton therapy (introduction, History), Wikipedia
- Particle therapy, Wikipedia
The frameworks of Radiation Oncology
Each framework is a way of working the field has used: when it held, and the question it answers.
- 1896-1925
- 1910-Present
- 1920-Present
- 1925-Present
Dosimetry and Radiological Physics
How much radiation is being delivered?
- 1950-Present
Megavoltage External-Beam Therapy
How can radiation reach tumors deep in the body?
- 1955-Present
- 1968-Present
- 1970-Present
Randomized Trial Evidence Base
Does a new treatment actually work better?
- 1985-Present
Three-Dimensional Conformal Radiotherapy
How can beams be shaped to fit a tumor's outline?
- 1995-Present
Intensity-Modulated Radiation Therapy
How can beam intensity be varied across a field?
- 2000-Present
Image-Guided and Adaptive Radiotherapy
How can treatment be adjusted to the patient's actual position?
How the ideas connect
Each arrow runs from an earlier idea to the later one it shaped. The list below says what passed between them.
Dosimetry and Radiological Physics influenced by Empirical radiotherapy
The empirical era's central problem—that dose could not be measured or reproduced, and that unmeasured exposure caused burns and cancers—created the demand for a quantitative unit. The roentgen, defined in 1928, and the International Commission on Radiological Units answered that demand directly.
Carried by International Commission on Radiological Units.
Intensity-Modulated Radiation Therapy grew out of Three-Dimensional Conformal Radiotherapy
IMRT grew directly out of 3D-CRT by adding intensity modulation across the field through multileaf collimator beamlets. Inverse planning, in which the desired dose distribution is specified and a computer searches for beamlet intensities, was the specific technical step that carried 3D-CRT into IMRT.
Dose fractionation influenced by Empirical radiotherapy
Empirical radiotherapy's observation that repeated small exposures produced tumor shrinkage with less normal-tissue injury fed directly into the fractionation concept. Claudius Regaud's work with radium at the Institut Curie in the early 1900s built on these clinical observations to show that divided doses spared normal tissue while sterilizing tumor.
Carried by Claudius Regaud.
Dosimetry and Radiological Physics influenced by Brachytherapy
Brachytherapy's need to specify dose around implanted radium sources drove the development of systematic dose specification. The Manchester system of the 1930s introduced a more rigorous way of describing dose distributions around implants, feeding into the broader discipline of dosimetry.
Carried by Manchester system.
Randomized Trial Evidence Base influenced by Dose fractionation
Fractionation established a standard curative schedule—roughly 2 Gy per day to about 60 Gy—that became the comparator arm in randomized trials. The randomized evidence base of the 1970s onward tested these fractionation schemes against alternatives and against surgery.
Megavoltage External-Beam Therapy influenced by Dosimetry and Radiological Physics
Dosimetry and radiological physics provided the measurement and calculation tools needed to characterize megavoltage beams and verify their depth-dose behavior. Physicists working with cobalt-60 units and early linacs used these dosimetric methods to establish the clinical use of megavoltage therapy.
Three-Dimensional Conformal Radiotherapy influenced by Dosimetry and Radiological Physics
Three-dimensional conformal radiotherapy depended on dose calculation in three dimensions, a direct extension of dosimetric physics. Treatment-planning computers built on established dose algorithms to design beams conforming to tumor shape from multiple directions.
Radiosurgery influenced by Megavoltage External-Beam Therapy
Linear-accelerator-based radiosurgery, developed in the 1980s, used megavoltage linacs to deliver converging beams to small intracranial targets. This extended Leksell's Gamma Knife concept onto the standard megavoltage platform.
Three-Dimensional Conformal Radiotherapy influenced by Megavoltage External-Beam Therapy
Megavoltage linacs provided the sharp-edged, deeply penetrating beams and the multileaf collimators that made conformal field shaping practical. 3D-CRT was built on the linac platform, adding CT-based planning and computer-controlled field shaping to the megavoltage beam.
Image-Guided and Adaptive Radiotherapy influenced by Radiosurgery
Stereotactic radiosurgery's demand for extreme geometric precision drove the development of image guidance and motion management. Stereotactic body radiotherapy extended these precision requirements outside the brain, relying on image-guided and adaptive techniques to track or account for setup variation and breathing.
Image-Guided and Adaptive Radiotherapy influenced by Intensity-Modulated Radiation Therapy
IMRT's tight dose gradients made small delivery errors consequential, creating the need for rigorous quality assurance and accurate patient positioning. Image-guided radiotherapy developed in part to verify and correct setup before each IMRT fraction, and adaptive radiotherapy extended this to replanning on the basis of imaging.
Beyond the field
Where Radiation Oncology's ideas came from in other fields, and what they led to there: the strongest 12 of 24 links.
Empirical radiotherapy led to Dosimetry in Imaging Physics
Dosimetry grew directly out of empirical radiotherapy: early practitioners dosed by skin reaction and exposure time, and the need to standardise the unit of quantity, culminating in the röntgen and the ICRU in 1928, produced the measurement science. Dosimetry is the refinement of empirical radiotherapy's trial-and-error dosing into a quantitative discipline.
Carried by International Commission on Radiation Units and Measurements.
Empirical radiotherapy led to Fractionated Radiotherapy in Oncology
Fractionated radiotherapy grew directly out of empirical radiotherapy: early practitioners observed that dividing dose into fractions spared skin while still controlling tumour, and this observation was systematised into fractionation schedules.
Radiosurgery grew out of Stereotactic surgery in Neurosurgery
Leksell developed stereotactic surgery and its frame-based cranial localization in the late 1940s, then extended the same apparatus to focused irradiation, giving radiosurgery its targeting method and name.
Carried by Lars Leksell.
Three-Dimensional Conformal Radiotherapy grew out of Fractionated Radiotherapy in Oncology
Three-dimensional conformal radiotherapy is fractionated radiotherapy refined by CT-based three-dimensional planning: it kept the fractionation scheme and replaced planar field arrangement with shaped beams fitted to a defined target volume.
Three-Dimensional Conformal Radiotherapy influenced by CT scan in Neuroimaging
Computed tomography, introduced in the early 1970s, gave radiotherapy the three-dimensional anatomical dataset needed to delineate target volumes and design conformal beams; conformal therapy is unthinkable without it.
Carried by Godfrey Hounsfield.
Intensity-Modulated Radiation Therapy grew out of Fractionated Radiotherapy in Oncology
Intensity-modulated radiotherapy is fractionated radiotherapy carried out with computer-optimized non-uniform beam fluences; it retains fractionation and the target-volume framework while adding inverse planning.
Image-Guided and Adaptive Radiotherapy grew out of Fractionated Radiotherapy in Oncology
Image-guided and adaptive radiotherapy is fractionated radiotherapy refined by imaging at each treatment and by replanning to the observed anatomy; it keeps the fractionated course and adds verification and adaptation.
Empirical radiotherapy influenced by Electrical engineering and circuit theory in Electromagnetism
Radiotherapy apparatus, X-ray tubes, high-voltage generators and later the Coolidge tube came directly from electrical engineering and circuit theory. The practical control of current and voltage made reproducible radiation delivery possible in the early empirical era.
Carried by William David Coolidge.
Empirical radiotherapy grew out of Radioactivity and Nuclear Spectroscopy in Nuclear Physics
Empirical radiotherapy grew directly out of the discovery of radioactivity and the observation that radioactive emissions damaged tissue. Early clinical use of radium and X-rays was an application of the new radioactive phenomena.
Empirical radiotherapy influenced Urologic oncology in Urology
Empirical radiotherapy's dose-fractionation practice and its early use against pelvic tumors gave urologic oncology its first nonsurgical treatment for prostate and bladder cancer. The radiation techniques developed in gynecologic and general radiotherapy were applied to urologic tumors in the mid-twentieth century.
Brachytherapy influenced Fractionated Radiotherapy in Oncology
Brachytherapy's practice of delivering dose in divided sessions informed the fractionation principle later applied to external-beam radiotherapy.
Brachytherapy influenced by Radiography in Imaging Physics
Brachytherapy depended on radiographic localisation of sources and tumours, using X-ray imaging to place radium applicators and verify their position. Radiography supplied the anatomical check that made intracavitary treatment controllable.

Radiation Oncology is a planet in Nousfarer
Its city has a tower for each of these 11 frameworks. Land, walk in, and climb one concept at a time.
Land on Radiation OncologyRelated fields
Fields its ideas are linked to
- Neurosurgery 8 links
- Oncology 6 links
- Imaging Physics 4 links
- Neuroimaging 1 link
- Surgical Oncology 1 link
- Electromagnetism 1 link
- Nuclear Physics 1 link
- Particle Physics 1 link
- Urology 1 link
More in Oncology
- Cancer Prevention And Screening
- Hematologic Malignancies
- Medical Oncology
- Oncology
- Precision Oncology
- Surgical Oncology
See where Radiation Oncology sits on the Map of Human Knowledge